Latest Lead News

Block, Inc. reported robust financial results for 2025, driven by Cash App and Square growth, while announcing a significant workforce reduction to accelerate AI-driven innovation and efficiency.

Hubify has completed a strategic $250,000 placement at a striking 425% premium to fund its AI-first growth strategy, including a key partnership with HubLab to deliver AI-powered ICT and cybersecurity services.

Polymetals Resources has reported its maiden revenue from the Endeavor Mine with first concentrate shipments, yet posted a substantial half-year loss of $34.5 million. Operational setbacks and exploration advances mark a pivotal phase for the company.

BetMakers Technology Group Ltd reported an 11.4% rise in half-year revenue to $46.1 million alongside a dramatic 80% reduction in losses, setting the stage for accelerated global growth and a strategic US market push.

Impact Minerals’ recent magneto-telluric survey at Broken Hill reveals a deep conductive corridor linked to near-surface anomalies, hinting at a large-scale mineral system beneath one of Australia’s most iconic mining districts.

Summerset Group Holdings delivered a record underlying profit of NZ$234.2 million in FY25, driven by strong sales and portfolio growth, while advancing its Australian village developments. Despite a dip in IFRS net profit due to portfolio revaluations, the company maintains a positive outlook with high resident satisfaction and sustainability milestones.

Ariadne Australia Ltd reported a modest net profit of $2.8 million for the half-year ended December 2025, underpinned by strong growth in its Orams Group investment and key strategic assets despite foreign exchange headwinds.

GreenHy2 Limited narrowed its net loss by 16% in FY2025, driven by government grants and initial sales of its new sodium-ion batteries. Strategic partnerships and product diversification position the company for growth in renewable energy storage.

Neurotech International reports a dramatic reduction in half-year losses alongside significant clinical and regulatory progress for its lead cannabinoid therapy NTI164. The company also strengthens its cash position through a $4 million placement and a $4.7 million R&D tax refund.

Patrys Limited reported a near doubling of its half-year loss to $3.02 million, driven by restructuring and a strategic pivot including the acquisition of Reliis Pty Ltd. The company is advancing a dual-platform biotech strategy combining a clinical-stage CNS asset with its proprietary antibody platform.

Biotron Limited reported a half-year loss as it completed the acquisition of Sedarex Limited and advanced its Hepatitis B drug candidate BIT-HBV001, backed by a $2.5 million capital raise. The company faces material uncertainty over its going concern status, hinging on securing further funding.

AVADA Group Limited reported an 11% revenue increase to $101.5 million in H1 FY26, driven by strong growth in Queensland and New South Wales and early gains from its business transformation. Despite a statutory loss, adjusted EBITDA improved, setting the stage for a stronger second half.